Levopront

Levodropropizine, the active ingredient in Levopront, is an antitussive presented as an oral formulation for oral use. It is used to relieve cough, particularly non‑productive or dry cough, in adults and children as directed.

GNH USA supplies Levopront as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Manufactured under European Union pharmaceutical guidelines, Levopront meets the requirements for safety, efficacy, and consistency.

Levopront, containing levodropropizine, is used to suppress cough by acting on the peripheral cough reflex pathway.

- Non‑productive cough: Reduces frequency and intensity of dry cough without producing sputum. - Acute cough: Provides symptomatic relief during short‑term respiratory infections. - Cough associated with throat irritation: Alleviates irritation‑induced cough episodes.

Levodropropizine may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: Mild stomach upset or queasiness. - Diarrhea: Loose stools occurring during treatment. - Headache: Transient head pain. - Dizziness: Light‑headed sensation. - Abdominal discomfort: Mild pain or cramps in the stomach area. - Dry mouth: Reduced salivation.

Serious or Rare Side Effects: - Allergic reaction: Rash, itching, or urticaria indicating hypersensitivity. - Anaphylaxis: Rare severe systemic allergic response requiring immediate medical attention. - Hepatic dysfunction: Elevated liver enzymes reported rarely.

When using Levopront, certain precautions should be observed to ensure safe and effective use.

- Indication: Use only for dry or non‑productive cough as directed. - Contraindication: Avoid in patients with known hypersensitivity to levodropropizine. - Caution: Do not use in productive cough with sputum production without medical advice. - Hepatic impairment: Use with caution in patients with liver disease; monitor liver function if needed. - Dosage: Do not exceed the recommended amount; follow prescriber instructions. - Store at ambient temperature: Keep below 25 °C, in the original packaging, protected from moisture and light.

Levodropropizine can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Combined use with other antitussives containing codeine: May increase risk of respiratory depression. - Concomitant use with monoamine oxidase inhibitors (MAOIs): Potential for enhanced serotonergic effects.

Moderate Interactions (Monitor Closely): - Sedatives or CNS depressants (e.g., antihistamines, benzodiazepines): May potentiate drowsiness. - Antihistamines: May increase antitussive effect, monitor cough suppression. - Alcohol: Can enhance sedation and dizziness.